ltrasound guided corticosteroid injection for plantar fasciitis: a randomised controlled trial

Active, not recruiting

• Conditions: Plantar fasciitis; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12610000239066
• Lead Sponsor: Department of Podiatry, La Trobe University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

History of pain beneath the heel for minimum 8 weeks

Minimum heel pain magnitude of 20mm on visual analogue scale

Sensitivity to palpation of medial calcaneal tubercle and/or the proximal plantar fascia

Minimum plantar fascia thickness value of 4.0mm as measured by ultrasound

Exclusion Criteria

Corticosteroid injection for plantar fasciitis within previous 6 months. Known hypersensitivity to lignocaine or dexamethasone. Current skin or soft tissue infection near injection site. Current pregnancy. Systemic inflammatory disease. Diabetes Mellitus. Previous local surgery or trauma. Commencement of any treatment for plantar fasciitis within four weeks prior to enrolment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain measured on a visual analogue scale[Baseline, then 1, 2 and 3 months post randomisation];Plantar fascia thickness measured by diagnostic ultrasound[Baseline, then 1, 2 and 3 months post randomisation]

Secondary Outcome Measures

Name	Time	Method
Function measured by the Foot Health Status Questionnaire[Baseline, then 1, 2 and 3 months post randomisation];Daily use of oral analgesic medication, self-reported in a diary[Baseline, then 1, 2 and 3 months post randomisation];First step pain measured on a visual analogue scale[Baseline, then 1, 2 and 3 months post randomisation]